Application
Research CategoryInfectious Diseases
Anti-Influenza B Antibody, clone B2 detects level of Influenza B & has been published & validated for use in IF.
Indirect Immunofluorescence
Optimal dilutions must be determined by end user.
Research Sub CategoryInfectious Diseases - Viral
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Immunogen
Influenza B
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Physical form
Format: Purified
Purified, FITC conjugated. Liquid in 0.02M phosphate buffer, 0.25M sodium chloride, pH 7.6 with 15 mg/mL BSA and 0.1% sodium azide
Specificity
Specific for the nucleoprotein antigen of Influenza B. No cross-reactivity to influenza A, parainfluenza 1, 2 or 3, adenovirus or RSV.
Storage and Stability
Store at 2° to 8°C.
This product has met the following criteria to qualify for the following awards: